Clinical Research Directory
Browse clinical research sites, groups, and studies.
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Sponsor: Novartis Pharmaceuticals
Summary
The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica.
Official title: A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR)
Key Details
Gender
All
Age Range
50 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
288
Start Date
2024-06-28
Completion Date
2028-08-22
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
Secukinumab
2 x 150mg/1mL PFS secukinumab
Locations (115)
Arizona Arthritis and Rheumatology Associates PLLC
Avondale, Arizona, United States
Sun Valley Arthritis Center Ltd
Peoria, Arizona, United States
Orrin Troum MD and Medical Associates
Santa Monica, California, United States
Center for Rheumatology Research
West Hills, California, United States
Millennium Clinical Trials
Westlake Village, California, United States
Rheumatology Associates of South Florida
Boca Raton, Florida, United States
UF Health Cancer Center
Gainesville, Florida, United States
Sarasota Arthritis Res Ctr
Sarasota, Florida, United States
West Broward Rheumatology Associates Inc
Tamarac, Florida, United States
Arthritis Center of North Georgia
Gainesville, Georgia, United States
Klein and Associates
Hagerstown, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Clinical Research Inst of MI
Saint Clair Shores, Michigan, United States
Kansas City Physician Partners
Kansas City, Missouri, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Paramount Med Rsrch and Consult LLC
Middleburg Heights, Ohio, United States
Prolato Clinical Research Center
Houston, Texas, United States
Accurate Clinical Research Inc
San Antonio, Texas, United States
Advanced Rheumatology of Houston
Spring, Texas, United States
Novartis Investigative Site
Quilmes, Buenos Aires, Argentina
Novartis Investigative Site
Buenos Aires, Argentina
Novartis Investigative Site
Parramatta, New South Wales, Australia
Novartis Investigative Site
Southport, Queensland, Australia
Novartis Investigative Site
Heidelberg Heights, Victoria, Australia
Novartis Investigative Site
Leuven, Belgium
Novartis Investigative Site
Liège, Belgium
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
São Paulo, São Paulo, Brazil
Novartis Investigative Site
São Paulo, Brazil
Novartis Investigative Site
Québec, Quebec, Canada
Novartis Investigative Site
Viña del Mar, Región de Valparaíso, Chile
Novartis Investigative Site
Santiago, Santiago Metropolitan, Chile
Novartis Investigative Site
Santiago, Santiago Metropolitan, Chile
Novartis Investigative Site
Santiago, Santiago Metropolitan, Chile
Novartis Investigative Site
Barranquilla, Atlántico, Colombia
Novartis Investigative Site
Barranquilla, Atlántico, Colombia
Novartis Investigative Site
Bogota, Cundinamarca, Colombia
Novartis Investigative Site
Cali, Valle del Cauca Department, Colombia
Novartis Investigative Site
Prague, Czech Republic, Czechia
Novartis Investigative Site
Brno, Czechia
Novartis Investigative Site
Hlučín, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Uherské Hradiště, Czechia
Novartis Investigative Site
Zlín, Czechia
Novartis Investigative Site
Esbjerg, Denmark
Novartis Investigative Site
Gandrup, Denmark
Novartis Investigative Site
Vejle, Denmark
Novartis Investigative Site
Limoges, Haute Vienne, France
Novartis Investigative Site
Toulon, Val De Marne, France
Novartis Investigative Site
Brest, France
Novartis Investigative Site
Cholet, France
Novartis Investigative Site
Colmar, France
Novartis Investigative Site
Dijon, France
Novartis Investigative Site
Le Mans, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Nantes, France
Novartis Investigative Site
Reims, France
Novartis Investigative Site
Strasbourg, France
Novartis Investigative Site
Toulouse, France
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Novartis Investigative Site
Würzburg, Bavaria, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Herne, Germany
Novartis Investigative Site
Ratingen, Germany
Novartis Investigative Site
Rendsburg, Germany
Novartis Investigative Site
Budapest, Hungary
Novartis Investigative Site
Szeged, Hungary
Novartis Investigative Site
Veszprém, Hungary
Novartis Investigative Site
Ramat Gan, Israel
Novartis Investigative Site
Bolzano, BZ, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Perugia, PG, Italy
Novartis Investigative Site
Pavia, PV, Italy
Novartis Investigative Site
Reggio Emilia, RE, Italy
Novartis Investigative Site
Fukuoka, Fukuoka, Japan
Novartis Investigative Site
Asahikawa, Hokkaido, Japan
Novartis Investigative Site
Kita-gun, Kagawa-ken, Japan
Novartis Investigative Site
Sagamihara, Kanagawa, Japan
Novartis Investigative Site
Yokohama, Kanagawa, Japan
Novartis Investigative Site
Nagano, Nagano, Japan
Novartis Investigative Site
Kawachi-Nagano, Osaka, Japan
Novartis Investigative Site
Bunkyo Ku, Tokyo, Japan
Novartis Investigative Site
Fuchū, Tokyo, Japan
Novartis Investigative Site
Ōme, Tokyo, Japan
Novartis Investigative Site
Shimonoseki, Yamaguchi, Japan
Novartis Investigative Site
Chūō, Yamanashi, Japan
Novartis Investigative Site
Okayama, Japan
Novartis Investigative Site
Osaka, Japan
Novartis Investigative Site
Beirut, Lebanon
Novartis Investigative Site
Guadalajara, Jalisco, Mexico
Novartis Investigative Site
Almelo, Overijssel, Netherlands
Novartis Investigative Site
Rotterdam, South Holland, Netherlands
Novartis Investigative Site
Groningen, Netherlands
Novartis Investigative Site
Bytom, Poland
Novartis Investigative Site
Lublin, Poland
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Cape Town, Western Cape, South Africa
Novartis Investigative Site
Cape Town, Western Cape, South Africa
Novartis Investigative Site
Sabadell, Barcelona, Spain
Novartis Investigative Site
Bilbao, Bizkaia, Spain
Novartis Investigative Site
A Coruña, Spain
Novartis Investigative Site
Barcelona, Spain
Novartis Investigative Site
Madrid, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Valencia, Spain
Novartis Investigative Site
Basel, Switzerland
Novartis Investigative Site
Sankt Gallen, Switzerland
Novartis Investigative Site
Barnet, United Kingdom
Novartis Investigative Site
Hull, United Kingdom
Novartis Investigative Site
Wolverhampton, United Kingdom